Impact of dietary resistant starch type 4 on human gut microbiota and immunometabolic functions

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Upadhyaya, Bijaya ^a   McCormack, Lacey ^a   Fardin Kia, Ali Reza ^b   Juenemann, Robert ^a   Nichenametla, Sailendra ^a   Clapper, Jeffrey ^a   Specker, Bonny ^a   Dey, Moul ^a  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; BACTERIAL DNA; RNA 16S; STARCH; VOLATILE FATTY ACID;

BACTEROIDES; BLOOD; CASE CONTROL STUDY; CHEMISTRY; DIET; DNA SEQUENCE; DRUG EFFECT; EUBACTERIUM; FECES; GENETICS; HUMAN; IMMUNOLOGY; INTESTINE FLORA; ISOLATION AND PURIFICATION; MASS FRAGMENTOGRAPHY; METABOLIC SYNDROME X; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; PRINCIPAL COMPONENT ANALYSIS; WAIST CIRCUMFERENCE;

ADIPOKINES; BACTEROIDES; CASE-CONTROL STUDIES; DIET; DNA, BACTERIAL; EUBACTERIUM; FATTY ACIDS, VOLATILE; FECES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GASTROINTESTINAL MICROBIOME; HUMANS; METABOLIC SYNDROME; PRINCIPAL COMPONENT ANALYSIS; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; STARCH; WAIST CIRCUMFERENCE;

EID: 84977079387     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep28797     Document Type: Article

References (47)

1. Lakka, H. M. et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288, 2709-2716 (2002).
2. Mozaffarian, D. et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 131, e29-322, doi: 10.1161/CIR.0000000000000152 (2015).
3. Yadav, D. et al. Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central India. Glob J Health Sci 5, 142-155, doi: 10.5539/gjhs.v5n6p142 (2013).
4. Webb, D. & Byrd-Bredbenner, C. Overcoming consumer inertia to dietary guidance. Adv Nutr 6, 391-396, doi: 10.3945/an.115.008441 (2015).
5. Dunbar-Jacob, J. et al. Adherence in chronic disease. Annu Rev Nurs Res 18, 48-90 (2000).
6. Nichenametla, S. N. et al. Resistant starch type 4-enriched diet lowered blood cholesterols and improved body composition in a double blind controlled cross-over intervention. Mol Nutr Food Res 58, 1365-1369, doi: 10.1002/mnfr.201300829 (2014).
7. Englyst, H. N., Kingman, S. M. & Cummings, J. H. Classification and measurement of nutritionally important starch fractions. Eur J Clin Nutr 46 Suppl 2, S33-50 (1992).
8. Martinez, I., Kim, J., Duffy, P. R., Schlegel, V. L. & Walter, J. Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLos One 5, e15046, doi: 10.1371/journal.pone.0015046 (2010).
9. Byrne, C. S., Chambers, E. S., Morrison, D. J. & Frost, G. The role of short chain fatty acids in appetite regulation and energy homeostasis. Int J Obes (Lond) 39, 1331-1338, doi: 10.1038/ijo.2015.84 (2015).
10. Graf, D. et al. Contribution of diet to the composition of the human gut microbiota. Microb Ecol Health Dis 26, 26164, doi: 10.3402/mehd.v26.26164 (2015).
11. Al-Tamimi, E. K., Seib, P. A., Snyder, B. S. & Haub, M. D. Consumption of Cross-Linked Resistant Starch (RS4(XL)) on Glucose and Insulin Responses in Humans. J Nutr Metab 2010, doi: 10.1155/2010/651063 (2010).
12. Shimotoyodome, A., Suzuki, J., Kameo, Y. & Hase, T. Dietary supplementation with hydroxypropyl-distarch phosphate from waxy maize starch increases resting energy expenditure by lowering the postprandial glucose-dependent insulinotropic polypeptide response in human subjects. Br J Nutr 106, 96-104, doi: 10.1017/S0007114510005854 (2011).
13. Lee, K. Y., Yoo, S.-H. & Lee, H. G. The effect of chemically-modified resistant starch, RS type-4, on body weight and blood lipid profiles of high fat diet-induced obese mice. Starch - Stärke 64, 78-85, doi: 10.1002/star.201100057 (2012).
14. Le Thanh-Blicharz, J. et al. Type IV resistant starch increases cecum short chain fatty acids level in rats. Acta Biochim Pol 61, 109-114 (2014).
15. Shimotoyodome, A., Suzuki, J., Fukuoka, D., Tokimitsu, I. & Hase, T. RS4-type resistant starch prevents high-fat diet-induced obesity via increased hepatic fatty acid oxidation and decreased postprandial GIP in C57BL/6J mice. Am J Physiol Endocrinol Metab 298, E652-662, doi: 10.1152/ajpendo.00468.2009 (2010).
16. Higgins, J. A. Resistant starch and energy balance: impact on weight loss and maintenance. Crit Rev Food Sci Nutr 54, 1158-1166, doi: 10.1080/10408398.2011.629352 (2014).
17. Topping, D. L. & Clifton, P. M. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81, 1031-1064 (2001).
18. Alberti, K. G., Zimmet, P., Shaw, J. & Group, I. D. F. E. T. F. C. The metabolic syndrome-a new worldwide definition. Lancet 366, 1059-1062, doi: 10.1016/S0140-6736(05)67402-8 (2005).
19. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140, doi: 10.1093/bioinformatics/btp616 (2010).
20. Fava, F. et al. The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome 'at-risk' population. Int J Obes (Lond) 37, 216-223, doi: 10.1038/ijo.2012.33 (2013).
21. Trumbo, P. et al. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc 102, 1621-1630 (2002).
22. Davenport, E. R. et al. Seasonal variation in human gut microbiome composition. PLos One 9, e90731, doi: 10.1371/journal. pone.0090731 (2014).
23. Yang, J. et al. Xylooligosaccharide supplementation alters gut bacteria in both healthy and prediabetic adults: a pilot study. Frontiers in Physiology 6, doi: 10.3389/fphys.2015.00216 (2015).
24. Fernandes, J., Su, W., Rahat-Rozenbloom, S., Wolever, T. M. S. & Comelli, E. M. Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans. Nutr Diab 4, e121, doi: 10.1038/nutd.2014.23 (2014).
25. Van den Abbeele, P. et al. Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. ISME J 7, 949-961, doi: 10.1038/ismej.2012.158 (2013).
26. Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796-1808, doi: 10.1172/JCI19246 (2003).
27. Scherer, P. E., Williams, S., Fogliano, M., Baldini, G. & Lodish, H. F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270, 26746-26749 (1995).
28. Rasouli, N. & Kern, P. A. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93, S64-73, doi: 10.1210/jc.2008-1613 (2008).
29. Cardellini, M. et al. C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. Diabetes Care 28, 2007-2012 (2005).
30. Kovatcheva-Datchary, P. et al. Dietary Fiber-Induced Improvement in Glucose Metabolism Is Associated with Increased Abundance of Prevotella. Cell Metab 22, 971-982, doi: 10.1016/j.cmet.2015.10.001 (2015).
31. Liu, G. Z. et al. High glucose/High Lipids impair vascular adiponectin function via inhibition of caveolin-1/AdipoR1 signalsome formation. Free Radic Biol Med 89, 473-485, doi: 10.1016/j.freeradbiomed.2015.09.005 (2015).
32. Greenfield, J. R. & Campbell, L. V. Relationship between inflammation, insulin resistance and type 2 diabetes: 'cause or effect'? Curr Diabetes Rev 2, 195-211 (2006).
33. Rankinen, T., Sarzynski, M. A., Ghosh, S. & Bouchard, C. Are there genetic paths common to obesity, cardiovascular disease outcomes, and cardiovascular risk factors? Circ Res 116, 909-922, doi: 10.1161/CIRCRESAHA.116.302888 (2015).
34. Delzenne, N. M. & Cani, P. D. Interaction between obesity and the gut microbiota: relevance in nutrition. Annu Rev Nutr 31, 15-31, doi: 10.1146/annurev-nutr-072610-145146 (2011).
35. Alphonse, P. A. & Jones, P. J. Revisiting Human Cholesterol Synthesis and Absorption: The Reciprocity Paradigm and its Key Regulators. Lipids, doi: 10.1007/s11745-015-4096-7 (2015).
36. Nyangale, E. P., Mottram, D. S. & Gibson, G. R. Gut microbial activity, implications for health and disease: the potential role of metabolite analysis. J Proteome Res 11, 5573-5585, doi: 10.1021/pr300637d (2012).
37. de Deckere, E. A., Kloots, W. J. & van Amelsvoort, J. M. Resistant starch decreases serum total cholesterol and triacylglycerol concentrations in rats. J Nutr 123, 2142-2151 (1993).
38. Ebel, B. et al. Impact of probiotics on risk factors for cardiovascular diseases. A review. Crit Rev Food Sci Nutr 54, 175-189, doi: 10.1080/10408398.2011.579361 (2014).
39. Voight, B. F. et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 380, 572-580, doi: 10.1016/S0140-6736(12)60312-2 (2012).
40. Morotomi, M., Nagai, F. & Watanabe, Y. Description of Christensenella minuta gen. nov., sp. nov., isolated from human faeces, which forms a distinct branch in the order Clostridiales, and proposal of Christensenellaceae fam. nov. Int J Syst Evol Microbiol 62, 144-149, doi: 10.1099/ijs.0.026989-0 (2012).
41. Goodrich, J. K. et al. Human genetics shape the gut microbiome. Cell 159, 789-799, doi: 10.1016/j.cell.2014.09.053 (2014).
42. Koropatkin, N. M., Cameron, E. A. & Martens, E. C. How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol 10, 323-335, doi: 10.1038/nrmicro2746 (2012).
43. Ravcheev, D. A., Godzik, A., Osterman, A. L. & Rodionov, D. A. Polysaccharides utilization in human gut bacterium Bacteroides thetaiotaomicron: comparative genomics reconstruction of metabolic and regulatory networks. BMC Genomics 14, 873, doi: 10.1186/1471-2164-14-873 (2013).
44. Flint, H. J., Scott, K. P., Duncan, S. H., Louis, P. & Forano, E. Microbial degradation of complex carbohydrates in the gut. Gut Microbes 3, 289-306, doi: 10.4161/gmic.19897 (2012).
45. Lombard, V., Golaconda Ramulu, H., Drula, E., Coutinho, P. M. & Henrissat, B. The carbohydrate-active enzymes database (CAZy) in 2013. Nucleic Acids Res 42, D490-495, doi: 10.1093/nar/gkt1178 (2014).
46. Satija, A., Yu, E., Willett, W. C. & Hu, F. B. Understanding nutritional epidemiology and its role in policy. Adv Nutr 6, 5-18, doi: 10.3945/an.114.007492 (2015).
47. Dewulf, E. M. et al. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62, 1112-1121, doi: 10.1136/gutjnl-2012-303304 (2013).